Answers are grounded in this paper and cite their sources.
Synthetic cell therapy is a field that has broad potential for future applications in human disease treatment. Next generation therapies will consist of engineered bacterial strains capable of diagnosing disease, producing and delivering therapeutics, and controlling their numbers to meet containment and safety concerns. A thorough understanding of the microbial ecology of the human body and the interaction of the microbes with the immune system will benefit the choice of an appropriate chassis that engrafts stably and interacts productively with the resident community in specific body niches.
No takes yet. Share an insight, caveat, or question.
Claesen et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: